ARWRVSSLS• Today (Normalized)
ARWR vs SLS (Arrowhead Pharmaceuticals Inc. vs SELLAS Life Sciences Group Inc.)
Showing Closing Date Range from Sep, 10 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ARWR Performance $82.85
+0.11%
Arrowhead Pharmaceuticals Inc.
Normalized Baseline0.00%
SLS Performance $11.55
-14.42%
SELLAS Life Sciences Group Inc.
Normalized Baseline0.00%
Alpha Spread Margin ARWR LEADS
+14.53%
ARWR outperforming by 14.53%
ARWRSLS
Spread TrajectoryToday (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ARWR SLS
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(2 dates)
| Date | ARWR Price | ARWR Gain (%) | SLS Price | SLS Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $82.85 | +0.11% | $11.55 | -14.42% | +14.53% |
| Sep 10, 2026 | $82.76 | +0.00% | $13.49 | +0.00% | +0.00% |